Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy

BMC Immunol. 2017 Dec 19;18(1):52. doi: 10.1186/s12865-017-0236-6.

Abstract

Background: Non-adherence has been associated with reduced graft survival. The aim of this study was to investigate the immunological mechanisms underlying chronic renal allograft rejection using a model of non-adherence to immunosuppressive therapy. We used a MHC (major histocompatibility complex) -mismatched rat model of renal transplantation (Brown Norway to Lewis), in which rats received daily oral cyclosporine A. In analogy to non-adherence to therapy, one group received cyclosporine A on alternating days only. Rejection was histologically graded according to the Banff classification. We quantified fibrosis by trichrome staining and intra-graft infiltration of T cells, B cells, and monocytes/macrophages by immunohistochemistry. The distribution of B lymphocytes was assessed using immunofluorescence microscopy. Intra-graft chemokine, chemokine receptor, BAFF (B cell activating factor belonging to the TNF family), and immunoglobulin G transcription levels were analysed by RT-PCR. Finally, we evaluated donor-specific antibodies (DSA) and complement-dependent cytotoxicity using flow cytometry.

Results: After 28 days, cellular rejection occurred during non-adherence in 5/6 animals, mixed with humoral rejection in 3/6 animals. After non-adherence, the number of T lymphocytes were elevated compared to daily immunosuppression. Monocyte numbers declined over time. Accordingly, lymphocyte chemokine transcription was significantly increased in the graft, as was the transcription of BAFF, BAFF receptor, and Immunoglobulin G. Donor specific antibodies were elevated in non-adherence, but did not induce complement-dependent cytotoxicity.

Conclusion: Cellular and humoral rejection, lymphocyte infiltration, and de novo DSA are induced in this model of non-adherence.

Keywords: BAFF; Donor specific antibodies; Humoral rejection; Leukocyte infiltration; Non-adherence; Renal transplantation.

MeSH terms

  • Allografts / drug effects
  • Allografts / immunology*
  • Allografts / pathology
  • Animals
  • Antibodies / blood
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Cyclosporine / administration & dosage*
  • Cyclosporine / pharmacology
  • Cytokines / drug effects
  • Cytokines / genetics
  • Graft Rejection / immunology*
  • Histocompatibility Antigens / immunology*
  • Immunoglobulin G / drug effects
  • Immunoglobulin G / genetics
  • Immunosuppression Therapy / methods*
  • Immunosuppression Therapy / standards
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacology
  • Kidney Transplantation / methods*
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • Models, Animal
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred Lew

Substances

  • Antibodies
  • Cytokines
  • Histocompatibility Antigens
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Cyclosporine